Literature DB >> 17651673

Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans.

Jacob J Clarenbach1, Gloria Lena Vega, Beverley Adams-Huet, Robert V Considine, Madia Ricks, Anne E Sumner.   

Abstract

BACKGROUND: African Americans commonly have normal high-density lipoprotein cholesterol (HDL-C) and low triglyceride levels despite having insulin resistance and obesity. The higher than expected HDL-C levels are usually attributed to low levels of hepatic triglyceride lipase (HTGL) activity. Factors that regulate HTGL in African Americans are not well delineated.
METHODS: In the current study, HTGL activity was examined in relation to indices of body fat (body mass index [BMI] and waist circumference [WC]), insulin resistance (fasting plasma insulin and homeostasis model assessment of insulin resistance [HOMA-IR] index), and adipokines (adiponectin and leptin). Sixty-three African Americans (33 men, 30 women; median age 31 years, range 20-50 years; median BMI 28.6 kg/m2, range 19.7-54.7 kg/m2) had anthropometry and measurement of postheparin lipase activities (HTGL), plasma HDL-C, triglycerides, and plasma adiponectin.
RESULTS: HTGL correlated strongly with HDL-C (r = -.52, p < .0001) and adiponectin (r = -.49, p < .001). HTGL increased with BMI and WC (r = .297, p = .018 and r = .301, p = .016, respectively). Adiponectin correlated strongly with HDL-C (r = .50, p < .0001) and triglycerides (r = -.493, p < .001). From multiple regression models, 28% of HTGL variability among African Americans can be explained by adiponectin levels in combination with gender and 35% of HTGL is explained with HDL-C included in the model.
CONCLUSION: The data suggest that adiponectin is a significant metabolic concomitant of HTGL activity in African Americans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651673     DOI: 10.2310/6650.2007.07001

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  7 in total

1.  Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention.

Authors:  Mark D Deboer
Journal:  Expert Rev Endocrinol Metab       Date:  2011-03

2.  Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.

Authors:  R Goldberg; M Temprosa; J Otvos; J Brunzell; S Marcovina; K Mather; R Arakaki; K Watson; E Horton; E Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958

3.  Major components of metabolic syndrome and adiponectin levels: a cross-sectional study.

Authors:  Anize D von Frankenberg; Filipe V do Nascimento; Lucas Eduardo Gatelli; Bárbara L Nedel; Sheila P Garcia; Carolina Sv de Oliveira; Pedro Saddi-Rosa; André F Reis; Luis H Canani; Fernando Gerchman
Journal:  Diabetol Metab Syndr       Date:  2014-02-26       Impact factor: 3.320

Review 4.  Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.

Authors:  Hidekatsu Yanai; Hiroshi Yoshida
Journal:  Int J Mol Sci       Date:  2019-03-08       Impact factor: 5.923

Review 5.  Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.

Authors:  Julia T Stadler; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

6.  Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio.

Authors:  Gloria Lena Vega; Scott M Grundy
Journal:  J Obes       Date:  2013-03-06

7.  Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology.

Authors:  RuiJuan Chen; Yi Shu; Yi Zeng
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.